Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
USE OUR INTELLIGENCE

Positive News for the Treatment of Pulmonary Embolism
PHARMA & CLINICAL TRIALS
September 1, 2026

Positive News for the Treatment of Pulmonary Embolism

Pulmonary embolism (a blood clot in the lungs) is the third most common cause of…

USE OUR INTELLIGENCE September 1, 2026
Groundbreaking Clinical Trial Demonstrates First Potential Treatment That Could Prevent Millions of Annual Heart Failures and Deaths in Severe Heart Attack Patients
DISEASES
September 1, 2026

Groundbreaking Clinical Trial Demonstrates First Potential Treatment That Could Prevent Millions of Annual Heart Failures and Deaths in Severe Heart Attack Patients

Study tests a peri-reperfusion therapy designed to limit hemorrhagic myocardial injury after primary percutaneous coronary…

USE OUR INTELLIGENCE September 1, 2026
Every Organ Ages on Its Own Schedule—and the Schedules Are in Sync
NEUROLOGY & MENTAL HEALTH
September 1, 2026

Every Organ Ages on Its Own Schedule—and the Schedules Are in Sync

Structural aging atlas highlights hormonal signaling as a possible conductor We tend to think of…

USE OUR INTELLIGENCE September 1, 2026
Why Her Sister and Not Her: Inside the Gap That Schizophrenia Genetics Has Not Closed
DISEASES
September 1, 2026

Why Her Sister and Not Her: Inside the Gap That Schizophrenia Genetics Has Not Closed

Schizophrenia is 80% heritable, yet identical twins receive the same diagnosis less than half the…

USE OUR INTELLIGENCE September 1, 2026
RECOVER-VITAL Clinical Trial Finds No Benefit of Extended Duration of PAXLOVID for Long COVID
PHARMA & CLINICAL TRIALS
September 1, 2026

RECOVER-VITAL Clinical Trial Finds No Benefit of Extended Duration of PAXLOVID for Long COVID

This trial is part of the NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative, a…

USE OUR INTELLIGENCE September 1, 2026
Statins Are Associated with a Lower Risk of Dementia in Patients with Type 2 Diabetes
DISEASES
September 1, 2026

Statins Are Associated with a Lower Risk of Dementia in Patients with Type 2 Diabetes

Researchers assessed whether early initiation of statins after type 2 diabetes diagnosis was associated with…

USE OUR INTELLIGENCE September 1, 2026
Hidden Immune Cells in the Lung Could Lead to Better Flu Vaccines
RESEARCH
September 1, 2026

Hidden Immune Cells in the Lung Could Lead to Better Flu Vaccines

Researchers have discovered long-lived immune cells in the lungs that help the body remember past…

USE OUR INTELLIGENCE September 1, 2026
High Fertility Costs Push Americans Abroad for IVF Treatment
PUBLIC HEALTH
September 1, 2026

High Fertility Costs Push Americans Abroad for IVF Treatment

In the summer of 2024, Emilie and Justin Solomon found themselves on a top-secret mission…

USE OUR INTELLIGENCE September 1, 2026
Robot-Assisted Surgery Shows Clinical Advantages Over Laparoscopic Surgery for Gastric Cancer
PHARMA & CLINICAL TRIALS
August 24, 2026

Robot-Assisted Surgery Shows Clinical Advantages Over Laparoscopic Surgery for Gastric Cancer

Researchers find robotic gastrectomy reduces complications, blood loss, and hospital stay compared with laparoscopic surgery…

USE OUR INTELLIGENCE August 24, 2026
Insilico Medicine Convenes O3DC, an Open Consortium for Benchmark Quality in AI-Driven Drug Discovery
PHARMA & CLINICAL TRIALS
August 24, 2026

Insilico Medicine Convenes O3DC, an Open Consortium for Benchmark Quality in AI-Driven Drug Discovery

Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today…

USE OUR INTELLIGENCE August 24, 2026
Older Posts Newer Posts
Latest Posts
  • U.S. Has Lost Measles Elimination Status, Global Health Authorities Say
    VIRUSES & VACCINES
    U.S. Has Lost Measles Elimination Status, Global Health Authorities Say
    USE OUR INTELLIGENCE November 17, 2026
  • ‘A Hard Time’ as Federal Cuts Hobble Efforts To Stop Overdoses From Tainted Drugs
    PUBLIC HEALTH
    ‘A Hard Time’ as Federal Cuts Hobble Efforts To Stop Overdoses From Tainted Drugs
    USE OUR INTELLIGENCE November 17, 2026
  • Mayo Clinic Study Shows Blood Biomarker May Help Estimate Cognitive Impairment Risk
    DISEASES
    Mayo Clinic Study Shows Blood Biomarker May Help Estimate Cognitive Impairment Risk
    USE OUR INTELLIGENCE November 17, 2026
  • Study Probes How Step Trackers, Health Apps Relate to Exercise Levels
    TECHNOLOGY
    Study Probes How Step Trackers, Health Apps Relate to Exercise Levels
    USE OUR INTELLIGENCE November 17, 2026
  • Houston Has Highest Childhood Poverty, Disconnected Youth Rates Among Largest U.S. Metros, Rice Report Finds
    PUBLIC HEALTH
    Houston Has Highest Childhood Poverty, Disconnected Youth Rates Among Largest U.S. Metros, Rice Report Finds
    USE OUR INTELLIGENCE November 17, 2026
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT